Skip to main content
Aurora Cannabis Inc. logo

Aurora Cannabis Inc. — Investor Relations & Filings

Ticker · ACB ISIN · CA05156X8504 TSX Manufacturing
Open in API
Filings indexed 364 across all filing types
Latest filing 2021-11-16 Regulatory Filings
Country CA Canada
Listing TSX ACB

About Aurora Cannabis Inc.

https://www.auroramj.com/

Aurora Cannabis Inc. is a global leader in the production and distribution of cannabis and cannabis-derivative products. The company cultivates and sells a portfolio of products for both medicinal and recreational markets. Recognized as Canada's largest medical cannabis company and a trusted provider, Aurora focuses on innovative, science-based medical cannabis offerings, including dried flower and various derivative formats such as oils and edibles. The company maintains operations across 12 countries, emphasizing high-quality cultivation and rigorous product development to serve patients and consumers worldwide.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing the launch of a new genetics licensing business unit called Occo by Aurora Cannabis Inc. It focuses on business development, product innovation, and leadership appointments. There are no financial statements, regulatory filings, or detailed financial data presented. The content is primarily a corporate announcement about a new business initiative and leadership hire, not a financial report, earnings release, or regulatory filing. Therefore, it does not fit into categories like 10-K, IR, ER, or MANG. It is best classified as a general regulatory announcement or corporate news update, which falls under Regulatory Filings (RNS). The document length is 9206 characters, which is sufficient for a substantive announcement but lacks financial data or report content.
2021-11-16 English
Report of voting results.pdf
Regulatory Filings
2021-11-15 English
Interim MD&A - English.pdf
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Interim Management’s Discussion & Analysis (Unaudited)' for the three months ended September 30, 2021. It contains detailed financial and operational discussion, including comparative quarterly data, financial review, liquidity, capital resources, accounting policies, and risk factors. It references compliance with International Accounting Standards 34 - Interim Financial Reporting and Canadian disclosure requirements under National Instrument 51-102. The document is 15,000 characters long, indicating it is a full report rather than a brief announcement. The content and structure clearly identify it as an Interim / Quarterly Report (IR) rather than an Annual Report or a simple earnings release. Therefore, the appropriate classification is 'IR'. Q1 2022
2021-11-09 English
52-109F2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a Form 52-109F2 Certification of Interim Filings by the CFO of Aurora Cannabis Inc. It certifies the review and fair presentation of the interim financial report and interim MD&A for the period ended September 30, 2021. The document is primarily an officer certification letter confirming the accuracy and completeness of the interim filings, including disclosure controls and internal controls over financial reporting. It does not contain the actual interim financial statements or substantive financial data but rather attests to their correctness. According to the Certification Rule, such certification documents should be classified as Regulatory Filings (RNS) rather than as the interim report itself (IR). The document length is 3775 characters, which is relatively short and consistent with a certification letter rather than a full interim report.
2021-11-09 English
52-109F2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a Form 52-109F2 Certification of Interim Filings by the CEO of Aurora Cannabis Inc. It certifies the review and fair presentation of the interim financial report and interim MD&A for the period ended September 30, 2021. The document is primarily an officer certification attesting to the accuracy and completeness of the interim filings, including disclosure controls and internal controls over financial reporting. It does not contain the actual interim financial statements or substantive financial data but serves as a formal attestation as required by securities regulations. According to the Certification Rule, such certification documents should be classified as Regulatory Filings (RNS) rather than as the interim report itself (IR). The document length is 3779 characters, which is relatively short and consistent with a certification letter rather than a full interim report.
2021-11-09 English
News release - English.pdf
Interim / Quarterly Report Classification · 95% confidence The document is a detailed announcement of Aurora Cannabis's financial and operational results for the first quarter of fiscal 2022, including comprehensive financial data such as revenue, adjusted EBITDA, gross margins, cash flow, and balance sheet information. It also includes management commentary on business transformation, cost savings, and strategic outlook. The presence of extensive financial metrics, period comparisons, and operational highlights indicates this is a quarterly financial report rather than a brief earnings release or a simple announcement. The document also mentions a conference call to discuss these results, which is typical for quarterly reports. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). Q1 2022
2021-11-09 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.